Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus - from the Spanish National Health System perspective.

Mezquita-Raya, Pedro; Darbà, Josep; Ascanio, Meritxell; Ramírez de Arellano, Antonio.
Expert Rev Pharmacoecon Outcomes Res; 17(6): 587-595, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28649881